Mechanistic Pathways · 10 min read · 2027-09-23
Spirulina and IL-22
A cytokine that acts on epithelium, not immune cells — driving antimicrobial defense and barrier repair without inflammation.
IL-22: The Tissue-Targeted Cytokine
IL-22 is unique among IL-10 family cytokines: its receptor (IL-22RA1 + IL-10R2) is expressed almost exclusively on epithelial cells, not on immune cells. IL-22 signaling through JAK1/TYK2-STAT3 drives epithelial antimicrobial peptide production (REG3γ, defensins, S100A8/A9), mucin secretion, and proliferative repair — without recruiting inflammatory infiltrates.
ILC3 Cells: The Primary Source
Group 3 innate lymphoid cells (ILC3s) are lineage-negative lymphocytes residing in mucosal tissues, producing IL-22 and IL-17 in response to IL-23 and AhR ligands. ILC3-derived IL-22 maintains intestinal barrier function and antimicrobial defense against commensal-pathogen transition. Th22 cells (CD4+ T cells) provide additional IL-22, particularly in skin.
AhR Ligands Drive IL-22
Aryl hydrocarbon receptor (AhR) is essential for ILC3 development and IL-22 production. AhR ligands include tryptophan metabolites (indole-3-aldehyde, indole-3-acetate from gut bacteria), dietary cruciferous-vegetable-derived metabolites (DIM), and microbially-produced indoles. Spirulina's effect on Bifidobacterium and Lactobacillus enrichment increases AhR ligand production by 25–40% in 16S-tracked interventions.
Tryptophan Provision and Indole Metabolism
Spirulina's tryptophan content (~0.93% dry weight) provides substrate for both host tryptophan metabolism (serotonin, kynurenine) and microbial tryptophan metabolism (indoles). Microbial tryptophanase activity in enriched Lactobacillus/Bifidobacterium populations produces indole-3-aldehyde, the strongest endogenous AhR ligand. This pathway is upstream of IL-22 production and barrier repair.
Lung Mucosal Defense
Beyond the gut, IL-22 supports lung mucosal defense through epithelial antimicrobial peptide production and mucin secretion. ILC3-IL-22 axis is protective against respiratory infections including bacterial pneumonia. Spirulina interventions in respiratory infection models show enhanced IL-22 production and reduced lung damage.
Conclusion
Spirulina enhances IL-22 production through indirect AhR ligand provision (25–40% increase) via tryptophan substrate and microbiota-driven indole production, plus ILC3 expansion in mucosal tissues. Net effects include enhanced antimicrobial peptide production, improved barrier integrity, and faster epithelial repair after injury. The mucosal-specific action of IL-22 — driving defense and repair without inflammatory collateral — represents an underrecognized dimension of spirulina's gut and lung protective effects.